Faslodex Advanced Breast Cancer Local Chinese Study
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Anastrozole
Sponsor: AstraZeneca